Wilson Sonsini Goodrich & Rosati has advised DoorDash. Latham & Watkins, Fenwick & West have advised Wonder. DoorDash, a global leader in local commerce, has entered...
DoorDash Acquires Grubhub Campus Dining Business and Invests in Wonder
Tarsus Pharmaceuticals Signs Agreement to Acquire Alkeus Pharmaceuticals
Gunderson Dettmer has advised Tarsus Pharmaceuticals. Latham & Watkins has advised Alkeus Pharmaceuticals. Tarsus Pharmaceuticals (Nasdaq: TARS) has entered into a definitive agreement to acquire Alkeus...
Scribe Therapeutics Completes $155.51 Million Initial Public Offering and Private Placement
Fenwick has advised Scribe Therapeutics. Latham & Watkins has advised the underwriters. Scribe Therapeutics Inc., a clinical-stage biotechnology company specializing in in vivo CRISPR technologies, has...
Serapha Bio and Boundless Bio Announce Merger and $230 Million Private Placement
Gibson Dunn has advised Serapha Bio, Inc. Latham & Watkins has advised Boundless Bio, Inc. Serapha Bio, Inc., a privately held biotechnology company, and Boundless Bio,...
Mineralys Therapeutics Announces Royalty Repurchase, $500 Million Debt Facility, and $150 Million Equity Offering
Latham & Watkins LLP has advised Mineralys Therapeutics. Cleary Gottlieb has represented the underwriters, including BofA Securities Inc., Goldman Sachs & Co. LLC, and Evercore Group...
Mobia Medical Raises $150 Million in Initial Public Offering
Latham & Watkins LLP has advised Mobia Medical, Inc. Cleary Gottlieb has represented the underwriters. Mobia Medical, Inc., a commercial-stage medical device company, completed its initial...
Vaxcyte Completes $632.5 Million Public Offering of Common Stock
Skadden has advised Vaxcyte, Inc. Latham & Watkins LLP has advised the underwriters. Vaxcyte, Inc. has completed the closing of an underwritten public offering of 12,650,000...
Vir Biotechnology Completes $172.5 Million Public Offering of Common Stock
Gunderson Dettmer, with support from Ropes & Gray LLP, Sheppard, Mullin, Richter & Hampton LLP, and Fox Rothschild LLP, has advised Vir Biotechnology. Latham & Watkins...
Arcus Biosciences Completes $287.5 Million Common Stock Offering
Latham & Watkins has advised Arcus Biosciences. Gunderson Dettmer has advised the underwriters. Arcus Biosciences, a clinical-stage, global biopharmaceutical company listed on the NYSE under the...
GRAIL Announces $325 Million Private Placement
Gunderson Dettmer has advised Hims & Hers. Latham & Watkins has advised GRAIL, Inc. GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect...
HealthCare Royalty and Blue Owl Capital Acquire BridgeBio Pharma’s BEYONTTRA Royalty Interest for $300 Million
Gibson Dunn has advised HealthCare Royalty and Blue Owl Capital, and Latham & Watkins has advised BridgeBio Pharma. HealthCare Royalty and Blue Owl Capital have acquired...
Xilio Therapeutics’ $2.1 Billion Collaboration With AbbVie
Latham & Watkins advised AbbVie on the transaction, and Ropes & Gray advised Xilio Therapeutics. Xilio Therapeutics (Nasdaq: XLO) announced a strategic collaboration and option agreement...